Visijet Inc. Files For FDA Approval Of Epi-Tome; Product Currently Being Sold In Europe And Korea; Addresses $4 Billion Refractive Surgery Market
10/19/2005 5:11:42 PM
More...
|
Webcast Alert For Visijet Inc.: Trilogy Capital's Emerging Growth Microcap Forum Announces The Addition Of Two Keynote Speakers To Today's Webcast At 12 P.M. ET
10/19/2005 5:09:15 PM
More...
|